$0.24 0.00 (0%)
4/21/2009 3:57 PM

Favrille, Inc. (FVRL)

CAPS Rating: No stars

A biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system.

Results 1 - 18 of 19
Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
Smites 76.75 12/20/2007 Underperform 3W $2.09 -88.33% -21.25% +67.08
lionstan 89.24 9/19/2007 Underperform 5Y $3.09 -92.10% -25.01% +67.10
gators1n96 50.81 7/27/2007 Outperform 1Y $2.99 -91.84% -21.64% -70.21
Biodano < 20 6/21/2007 Outperform 3W $3.74 -93.48% -23.66% -69.82
canoic 25.19 5/17/2007 Underperform 1Y $3.60 -93.22% -23.48% +69.75
hannaron23 95.16 5/15/2007 Underperform 1Y $3.49 -93.01% -23.13% +69.88
djiddish98 99.65 5/7/2007 Outperform NS $4.14 -94.11% -23.26% -70.84
mikehav < 20 5/7/2007 Underperform 3M $4.08 -94.02% -23.22% +70.80
ProphetOfProfits 75.28 5/4/2007 Outperform 1Y $3.91 -93.76% -23.16% -70.60
happymillionsrmn < 20 4/23/2007 Underperform 5Y $3.91 -93.76% -21.93% +71.83 1 Comment
Belstock < 20 4/20/2007 Outperform 1Y $3.91 -93.76% -21.85% -71.91
tropimist 29.90 4/16/2007 Outperform 3M $4.12 -94.08% -20.57% -73.51
psychokids 32.74 4/16/2007 Outperform 5Y $4.12 -94.08% -20.57% -73.51
MalarkyMatt2 < 20 4/12/2007 Outperform NS $4.15 -94.12% -19.41% -74.71
biotiempo 54.38 4/10/2007 Outperform 1Y $3.90 -93.74% -19.97% -73.77
strangeralina < 20 4/10/2007 Outperform NS $4.07 -94.00% -19.74% -74.26
stoynalina 38.29 4/10/2007 Outperform NS $4.07 -94.00% -19.74% -74.26
pindari 26.97 4/4/2007 Outperform 5Y $3.55 -93.13% -19.38% -73.75
Results 1 - 18 of 19

Featured Broker Partners